Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia". |
Therapeutic use
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
1yVhcpBgdXnMPK3Y
